Arax Advisory Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Arax Advisory Partners's AMPH Position: Q2 2026 in Review
Arax Advisory Partners increased its Amphastar Pharmaceuticals (AMPH) stake by 2,912% in Q2 2026, buying an estimated $35.2K and bringing the position to 1,807 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3524.
Arax Advisory Partners first reported a position in AMPH in Q2 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Arax Advisory Partners held 1,807 shares of Amphastar Pharmaceuticals worth $36.5K as of Q2 2026.
- Arax Advisory Partners bought 1,747 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $35.2K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3524 holding.
- Arax Advisory Partners first reported a position in Amphastar Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.